ADJUVANT TREATMENT
Clinical trials for ADJUVANT TREATMENT explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT TREATMENT trials appear
Sign up with your email to follow new studies for ADJUVANT TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a pill keep lung cancer from returning after surgery?
Disease control Recruiting nowThis trial tests whether taking firmonertinib after surgery can help prevent non-small cell lung cancer from coming back in people with certain uncommon EGFR mutations. Participants who had their tumor completely removed will receive either firmonertinib or a placebo daily. The s…
Matched conditions: ADJUVANT TREATMENT
Phase: PHASE3 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New study aims to help women stick with Life-Saving breast cancer treatment
Symptom relief Recruiting nowAbout half of women stop taking aromatase inhibitors early due to side effects, raising the risk of cancer returning. This study tests whether switching to a different hormone drug or using other symptom-relief methods works better at managing those side effects. Researchers will…
Matched conditions: ADJUVANT TREATMENT
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC